Aspen Pharmacare Holdings Ltd
SWB:LDZA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aspen Pharmacare Holdings Ltd
SWB:LDZA
|
ZA |
|
Rewalk Robotics Ltd
NASDAQ:LFWD
|
IL |
|
Barclays PLC
LSE:BARC
|
UK |
|
C
|
Consolidated Edison Inc
XBER:EDC
|
US |
|
China Mobile Ltd
F:CTM
|
CN |
|
C
|
Christian Dior SE
DUS:DIO
|
FR |
|
I
|
IDEXX Laboratories Inc
LSE:0J8P
|
US |
|
Infineon Technologies AG
F:IFX
|
DE |
|
S
|
Sigma Healthcare Ltd
F:S5YA
|
AU |
|
F
|
First Quantum Minerals Ltd
F:IZ1
|
CA |
|
Uber Technologies Inc
BMV:UBER
|
US |
|
N
|
Northam Platinum Holdings Ltd
JSE:NPH
|
ZA |
|
Nestle SA
F:NESR
|
CH |
|
T
|
Tenet Healthcare Corp
SWB:THC1
|
US |
|
KDDI Corp
OTC:KDDIF
|
JP |
|
K
|
Kinder Morgan Inc
F:2KD
|
US |
|
I
|
Iss A/S
XMUN:QJQ
|
DK |
|
Park National Corp
F:PAZ
|
US |
|
S
|
State Street Corp
BMV:STT
|
US |
Wall St Price Targets
LDZA Price Targets Summary
Aspen Pharmacare Holdings Ltd
According to Wall Street analysts, the average 1-year price target for LDZA is 8.19 EUR with a low forecast of 7.38 EUR and a high forecast of 9.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LDZA's stock price target?
Price Target
8.19
EUR
According to Wall Street analysts, the average 1-year price target for LDZA is 8.19 EUR with a low forecast of 7.38 EUR and a high forecast of 9.58 EUR.
What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 4%.
